Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus Crispatus CTV-05 (LACTIN-V) to Prevent the Recurrence of Bacterial Vaginosis
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs CTV 05 (Primary) ; Metronidazole
- Indications Bacterial vaginosis
- Focus Adverse reactions; Therapeutic Use
- 12 Oct 2017 Planned primary completion date changed from 30 Sep 2017 to 30 Sep 2018.
- 09 Jun 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Sep 2017.
- 11 May 2016 Company expects completion of this trial in early 2018, according to an Osel Inc. media release.